The rapid generation of recombinant functional monoclonal antibodies from individual, antigen-specific bone marrow-derived plasma cells isolated using a novel fluorescence-based method.

Autor: Clargo AM; UCB Pharma; Berkshire, UK., Hudson AR; UCB Pharma; Berkshire, UK., Ndlovu W; UCB Pharma; Berkshire, UK., Wootton RJ; UCB Pharma; Berkshire, UK., Cremin LA; UCB Pharma; Berkshire, UK., O'Dowd VL; UCB Pharma; Berkshire, UK., Nowosad CR; UCB Pharma; Berkshire, UK., Starkie DO; UCB Pharma; Berkshire, UK., Shaw SP; UCB Pharma; Berkshire, UK., Compson JE; UCB Pharma; Berkshire, UK., White DP; UCB Pharma; Berkshire, UK., MacKenzie B; UCB Pharma; Berkshire, UK., Snowden JR; UCB Pharma; Berkshire, UK., Newnham LE; UCB Pharma; Berkshire, UK., Wright M; UCB Pharma; Berkshire, UK., Stephens PE; UCB Pharma; Berkshire, UK., Griffiths MR; UCB Pharma; Berkshire, UK., Lawson AD; UCB Pharma; Berkshire, UK., Lightwood DJ; UCB Pharma; Berkshire, UK.

Publikováno v: MAbs [MAbs] 2014 Jan-Feb; Vol. 6 (1), pp. 143-59.